Home
Boehringer Ingelheim

Boehringer Ingelheim Market Share Analysis for November 2025

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.

Health > Health - Other

Domainboehringer-ingelheim.co.uk

Year Founded1885

Employees> 10001

Annual Revenue> $1B

Boehringer Ingelheim

Boehringer Ingelheim (including company regionals)

boehringer-ingelheim.co.uk

See more website traffic and engagement information

Boehringer Ingelheim Revenue up to November 2025 is > 1B

revenue generated by Boehringer Ingelheim top domains

Boehringer Ingelheim top domains revenue over 3 years

Revenue for Boehringer Ingelheim top domains

boehringer-ingelheim.co.uk> 1B

See more with Sales Intelligence

Total visits to Boehringer Ingelheim's top domains

Understand Boehringer Ingelheim market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Boehringer Ingelheim's top domains

Analyze Boehringer Ingelheim engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Boehringer Ingelheim's top domains

See how Boehringer Ingelheim keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Boehringer Ingelheim top competitors by domain

Top similar sites in November 2025, ranked by their affinity

gsk.comCompany NameGSK plcEmployees> 10001HQUnited Kingdom, LondonAnnual revenue> $1BTotal visits906.8KHealth > Health - Other

Top technologies used by Boehringer Ingelheim

These are the website technologies, by industry, used by Boehringer Ingelheim top domains

Payment & Currencies (23)

PayPal

Conversion & Analytics (5)

Google Analytics

Social (4)

Instagram

Audio Video Media (3)

YouTube

More Technologies

6

See all

News & Signals from Boehringer Ingelheim

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBoehringer Ingelheim Limited hires Vani Manja as Country Managing Director and Head of Human Pharma.Boehringer Ingelheim UK & Ireland has appointed Vani Manja as its new Country Managing Director and Head of Human Pharma.

NewsBoehringer Ingelheim Limited acquired NBE Therapeutics AG for $1.2B on Jan 1st '20.The startup NBE-Therapeutics participated in the Venture Leaders program in 2003 and was acquired for EUR 1.18 billion by Boehringer Ingelheim in 2020.

NewsBoehringer Ingelheim Limited launches Prevexxion RN and Prevexxion RN+HVT+IBD, the next generation of Marek’s disease vaccines, in the European Union.Boehringer Ingelheim, a global leader in animal health, announced the launch of Prevexxion RN and Prevexxion RN+HVT+IBD, the next generation of Marek’s disease vaccines, in the European Union countries and the United Kingdom.